Nine studies [32, 34, 36, 38, 41–45] were recruited into our meta-analysis to assess the relationship of the dual-null genotype, of individuals lacking both GSTM1 and GSTT1, and the susceptibility of RCC (Fig. 1 and Table 1). Here, GSTM1 is linked to renal cell carcinoma.